Bladder Cancer

Prospective Analysis of Confocal Laser Endomicroscopy for Assessment of the Resection Bed for Bladder Tumor. December 23, 2024

FDA Approval Summary: Nadofaragene firadenovec-vncg for bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer. December 23, 2024

Low-cost and label-free blue light cystoscopy through digital staining of white light cystoscopy videos. December 20, 2024

Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer. December 20, 2024

Impact of immigration background on feasibility of electronic patient-reported outcomes in advanced urothelial cancer patients. December 20, 2024

Bladder sparing management for muscle-invasive bladder cancer after a complete clinical response: ready for prime time?-a narrative review. December 20, 2024

Prognostic Value of a B Cell Exhaustion Gene Signature in Bladder Cancer - Expert Commentary December 19, 2024

Retrospective analysis of partial cystectomy in patients with muscle-invasive urothelial carcinoma: A German single-center experience. December 19, 2024

A multimodal deep-learning model based on multichannel CT radiomics for predicting pathological grade of bladder cancer. December 19, 2024

Developing and experimental validating a B cell exhaustion-related gene signature to assess prognosis and immunotherapeutic response in bladder cancer. December 19, 2024

Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1). December 18, 2024

The Role of Antibody-Drug Conjugates in Urothelial Cancer: A Review of Recent Advances in the Treatment of Locally Advanced and Metastatic Urothelial Cancer. December 18, 2024

Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy. December 17, 2024

Perioperative immunotherapy in urothelial carcinoma: AMBASSADOR charts the path forward. December 17, 2024

Racial differences in carcinoma-in-situ and non-muscle-invasive bladder cancer mortality: Accounting for insurance status, black segregation, and neighborhood poverty. December 17, 2024

Benefits of Comprehensive Geriatric Assessment in Older Patients with Muscle-Invasive Bladder Cancer - Expert Commentary December 16, 2024

Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy with Intracorporeal Ileal Conduit. December 16, 2024

Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer. December 16, 2024

Survival after trimodal therapy in octogenarians with organ-confined urothelial bladder cancer. December 16, 2024

Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab. December 13, 2024

Page 1 of 523